应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
COR CENCORA
盘前交易 03-24 08:14:31 EDT
320.61
-6.30
-1.93%
盘前
320.61
+0.00
0.00%
08:05 EDT
最高
331.27
最低
320.20
成交量
138.27万
今开
329.77
昨收
326.91
日振幅
3.39%
总市值
621.96亿
流通市值
595.07亿
总股本
1.94亿
成交额
4.46亿
换手率
0.74%
流通股本
1.86亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
两大再保险巨头发布业绩
市场资讯 · 03-04
两大再保险巨头发布业绩
异动解读 | 特药需求激增提振行业前景，CENCORA盘中大涨5.16%
异动解读 · 02-05
异动解读 | 特药需求激增提振行业前景，CENCORA盘中大涨5.16%
异动解读 | 季度营收不及预期，CENCORA盘中大跌8.08%
异动解读 · 02-05
异动解读 | 季度营收不及预期，CENCORA盘中大跌8.08%
异动解读 | 季度营收不及预期，CENCORA盘前大跌5.35%
异动解读 · 02-04
异动解读 | 季度营收不及预期，CENCORA盘前大跌5.35%
穿透泰康在线2025年成绩单：保费突破200亿、综合投资收益率达5.57%
华尔街见闻 · 01-30
穿透泰康在线2025年成绩单：保费突破200亿、综合投资收益率达5.57%
财报前瞻｜CENCORA本季度营收预计增9.75%，机构观点偏乐观
财报Agent · 01-28
财报前瞻｜CENCORA本季度营收预计增9.75%，机构观点偏乐观
Cencora - 预计交易在关闭后首十二个月对公司的调整后摊薄每股收益影响为中性，融资成本净额考虑在内
美股速递 · 2025-12-15
Cencora - 预计交易在关闭后首十二个月对公司的调整后摊薄每股收益影响为中性，融资成本净额考虑在内
Cencora - 公司全年度调整后摊薄每股收益更可能位于其指引范围的下半部分，即17.45美元至17.75美元
美股速递 · 2025-12-15
Cencora - 公司全年度调整后摊薄每股收益更可能位于其指引范围的下半部分，即17.45美元至17.75美元
在股息不受追捧的美股市场中值得买入的15只派息股
老虎资讯综合 · 2025-11-20
在股息不受追捧的美股市场中值得买入的15只派息股
Cencora第四季度调整后的每股收益为3.84美元，符合IBES预期的3.79美元
投资观察 · 2025-11-20
Cencora第四季度调整后的每股收益为3.84美元，符合IBES预期的3.79美元
Cencora宣布计划到2030年投资10亿美元以增强和扩展其在美国的药品分销网络
美股速递 · 2025-11-05
Cencora宣布计划到2030年投资10亿美元以增强和扩展其在美国的药品分销网络
Cencora宣布至2030年投资10亿美元 加强美国分销网络、扩大产能与增强韧性
美股速递 · 2025-11-05
Cencora宣布至2030年投资10亿美元 加强美国分销网络、扩大产能与增强韧性
Cencora - 自2026年第一季度起，公司报告结构将包括美国医疗解决方案、国际医疗解决方案及其他
美股速递 · 2025-11-05
Cencora - 自2026年第一季度起，公司报告结构将包括美国医疗解决方案、国际医疗解决方案及其他
【方正金融】中国人保9M25业绩点评：COR边际大幅改善，人身险业务维持高增
市场资讯 · 2025-10-31
【方正金融】中国人保9M25业绩点评：COR边际大幅改善，人身险业务维持高增
【研报掘金｜华泰证券：上调中国再保险目标价至1.1港元 去年盈利超预期】华泰证券发表研究报告指，中国再保险预计2024年归母净利润按年升80%至100%，超出该行预期。该行认为，公司利润高速增长，或主要受投资业绩高增以及保险业务稳健增长的驱动。该行预计，集团2024年人身再保险业务净利润有望增长236%，2024年全年财险业务COR达99.8%。该行表示，考虑到投资波动，将上年、今年及明年每股盈测上调至分别0.25元、0.21元及0.21元，目标价则由1港元上调至1.1港元，维持其评级为“买入”。
金融界 · 2025-02-24
【研报掘金｜华泰证券：上调中国再保险目标价至1.1港元 去年盈利超预期】华泰证券发表研究报告指，中国再保险预计2024年归母净利润按年升80%至100%，超出该行预期。该行认为，公司利润高速增长，或主要受投资业绩高增以及保险业务稳健增长的驱动。该行预计，集团2024年人身再保险业务净利润有望增长236%，2024年全年财险业务COR达99.8%。该行表示，考虑到投资波动，将上年、今年及明年每股盈测上调至分别0.25元、0.21元及0.21元，目标价则由1港元上调至1.1港元，维持其评级为“买入”。
【沃尔格林联合博姿继续出售Cencora股份 套现约3亿美元】 美国连锁药店沃尔格林联合博姿周四表示，已出售更多药品分销商Cencora的股份，套现约3亿美元。该公司目前在Cencora的持股比例从10%降至6%。此次出售股份所得将主要用于偿还债务和一般公司用途。（智通财经）
金融界 · 2025-02-07
【沃尔格林联合博姿继续出售Cencora股份 套现约3亿美元】 美国连锁药店沃尔格林联合博姿周四表示，已出售更多药品分销商Cencora的股份，套现约3亿美元。该公司目前在Cencora的持股比例从10%降至6%。此次出售股份所得将主要用于偿还债务和一般公司用途。（智通财经）
Cencora 第一季度财报：肥胖药物和特殊药品推动收入和每股收益超预期
财报速递 · 2025-02-06
Cencora 第一季度财报：肥胖药物和特殊药品推动收入和每股收益超预期
Cencora(COR.US)：2025年Q1财报实现营收814.87亿美元，前值为722.53亿美元，预期值为782.2亿美元；每股收益为3.73美元，前值为3.28美元，预期值为3.52美元。
金融界 · 2025-02-05
Cencora(COR.US)：2025年Q1财报实现营收814.87亿美元，前值为722.53亿美元，预期值为782.2亿美元；每股收益为3.73美元，前值为3.28美元，预期值为3.52美元。
Cencora 2025年第一季度调整后每股收益$3.73，超过预期的$3.50，销售额为$814.9亿，超过预期的$783.8亿
财报速递 · 2025-02-05
Cencora 2025年第一季度调整后每股收益$3.73，超过预期的$3.50，销售额为$814.9亿，超过预期的$783.8亿
富国银行：维持Cencora(COR.US)评级，由持股观望调整至持股观望评级, 目标价由237.00美元调整至251.00美元。
金融界 · 2025-01-29
富国银行：维持Cencora(COR.US)评级，由持股观望调整至持股观望评级, 目标价由237.00美元调整至251.00美元。
加载更多
公司概况
公司名称：
CENCORA
所属市场：
NYSE
上市日期：
--
主营业务：
Cencora, Inc.是全球最大的药品采购和分销服务公司之一，帮助医疗保健供应商以及制药和生物技术制造商改善患者获得产品加强患者护理的机会。该公司提供创新计划和服务，旨在提高药品供应链在人类和动物健康方面的效力和效率。更具体地说，该公司向位于美国和部分全球市场的各种医疗保健提供商提供全面的品牌、专业品牌和非专利药品、非处方医疗产品、家庭医疗用品和设备以及相关服务，包括急性病医院和卫生系统、独立和连锁零售药店、邮购药房、诊所、长期护理和替代地点药房、医师执业、医疗和透析诊所、兽医和其他客户。此外，公司还为医疗保健提供商和制药制造商提供各种相关服务，包括数据分析、结果研究、报销和药物咨询服务、利基优质物流服务、库存管理、药房自动化、药房管理和包装解决方案。
发行价格：
--
{"stockData":{"symbol":"COR","market":"US","secType":"STK","nameCN":"CENCORA","latestPrice":320.61,"timestamp":1774296000000,"preClose":326.91,"halted":0,"volume":1382667,"hourTrading":{"tag":"盘前","latestPrice":320.61,"preClose":320.61,"latestTime":"08:05 EDT","volume":812,"amount":260585.90320000003,"timestamp":1774353905497,"change":0,"changeRate":0,"amplitude":0.0097},"delay":0,"changeRate":-0.019271359089657738,"floatShares":185606992,"shares":193993444,"eps":8.330479,"marketStatus":"盘前交易","change":-6.3,"latestTime":"03-24 08:14:31 EDT","open":329.77,"high":331.27,"low":320.2,"amount":445793825.20530003,"amplitude":0.033863,"askPrice":331.25,"askSize":6,"bidPrice":318.15,"bidSize":3,"shortable":3,"etf":0,"ttmEps":8.330479,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1285214400000,"exchange":"NYSE","adjPreClose":320.61,"dividendRate":0.007174,"preHourTrading":{"tag":"盘前","latestPrice":320.61,"preClose":320.61,"latestTime":"08:05 EDT","volume":812,"amount":260585.90320000003,"timestamp":1774353905497,"change":0,"changeRate":0,"amplitude":0.0097},"postHourTrading":{"tag":"盘后","latestPrice":320.61,"preClose":320.61,"latestTime":"18:26 EDT","volume":115604,"amount":37063800.4778,"timestamp":1774304802282,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6255392786242575,"impliedVol":0.3304,"impliedVolPercentile":0.972},"requestUrl":"/m/hq/s/COR","defaultTab":"news","newsList":[{"id":"2616630002","title":"两大再保险巨头发布业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2616630002","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616630002?lang=zh_cn&edition=full","pubTime":"2026-03-04 11:42","pubTimestamp":1772595720,"startTime":"0","endTime":"0","summary":" 近期，瑞士再保险、慕尼黑再保险两大国际再保险巨头发布2025年业绩。两家机构均实现盈利，综合成本率持续优化，偿付能力保持充足，并在最新续转中坚持严格承保纪律，审慎经营应对市场变化。 瑞再财产及意外险再保险2025年净收益28亿美元，高于2024年的12亿美元。财产及意外险再保险新业务CSM为27亿美元，2024年为29亿美元。 慕再人寿与健康再保险2025年实现整体承保业绩17.15亿欧元，板块净利润降至13.34亿欧元，保险业务收入121.79亿欧元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-03-04/doc-inhpuwsp0229076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4529","LU2237957902.USD","BK4084","MEURmain","SG9999004303.SGD","LU1084165304.USD","EURmain","LU1261432733.SGD","LU2324357040.USD","LU1814569148.SGD","LU1119994496.HKD","BK4588","LU0058720904.USD","BK4585","FXE","BK4077","LU2237957811.SGD","SGXZ23171101.USD","COR","EUO","ROE","LU1585245621.USD","LU1430594728.SGD","SST","CSM","BK4175","LU0289739699.SGD"],"gpt_icon":0},{"id":"1114739699","title":"异动解读 | 特药需求激增提振行业前景，CENCORA盘中大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114739699","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114739699?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:41","pubTimestamp":1770302507,"startTime":"0","endTime":"0","summary":"CENCORA(COR)今日盘中股价大幅上涨5.16%，表现显著强于大盘。消息面上，同行业公司卡地纳健康因特药需求激增而上调了年度利润预期。报道指出，卡地纳健康、CENCORA和McKesson等药品分销商正抓住治疗癌症和自身免疫性疾病等复杂疾病的高利润特种药品需求激增的浪潮，同时也受益于重磅药专利到期带来的仿制药市场顺风。这些因素共同提振了市场对药品分销行业，特别是其中主要参与者如CENCORA的未来增长和盈利能力的乐观预期，从而推动了其股价在交易时段的强劲表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["COR"],"gpt_icon":0},{"id":"1137931175","title":"异动解读 | 季度营收不及预期，CENCORA盘中大跌8.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137931175","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137931175?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:07","pubTimestamp":1770224865,"startTime":"0","endTime":"0","summary":"CENCORA(COR)今日盘中股价大幅下跌8.08%，引起了市场的广泛关注。消息面上，CENCORA公布的季度营收为859.3亿美元，低于分析师平均预期的860.3亿美元，这是导致股价下跌的主要原因。尽管该公司公布的第一季度利润为每股4.08美元，略高于分析师平均预期的每股4.04美元，但营收未达预期显然对市场信心造成了更大影响，从而引发了抛售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["COR"],"gpt_icon":0},{"id":"1149561818","title":"异动解读 | 季度营收不及预期，CENCORA盘前大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149561818","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149561818?lang=zh_cn&edition=full","pubTime":"2026-02-04 20:56","pubTimestamp":1770209786,"startTime":"0","endTime":"0","summary":"CENCORA(COR)今日盘前股价大跌5.35%，引发了市场的广泛关注。消息面上，公司公布的季度营收为859.3亿美元，低于分析师平均预期的860.3亿美元，这是导致股价下跌的主要原因。尽管该公司公布的第一季度利润为每股4.08美元，略高于分析师平均预期的每股4.04美元，但营收未达预期显然对市场信心造成了更大影响，从而引发了抛售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["COR"],"gpt_icon":0},{"id":"2607201645","title":"穿透泰康在线2025年成绩单：保费突破200亿、综合投资收益率达5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607201645","media":"华尔街见闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607201645?lang=zh_cn&edition=full","pubTime":"2026-01-30 17:23","pubTimestamp":1769764981,"startTime":"0","endTime":"0","summary":"作为泰康保险集团在互联网战场的排头兵，泰康在线已交出了2025年的“成绩单”。数据上看，泰康在线在2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3764588","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3764588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU2237957902.USD","LU1814569148.SGD","LU1261432733.SGD","BK4529","LU0058720904.USD","LU2237957811.SGD","BK4588","BK4585","SGXZ23171101.USD","BK4175","COR","LU1084165304.USD","BK4084","LU0289739699.SGD","LU1119994496.HKD","LU1585245621.USD","LU1430594728.SGD","SG9999004303.SGD"],"gpt_icon":0},{"id":"1183505326","title":"财报前瞻｜CENCORA本季度营收预计增9.75%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1183505326","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183505326?lang=zh_cn&edition=full","pubTime":"2026-01-28 10:15","pubTimestamp":1769566518,"startTime":"0","endTime":"0","summary":"CENCORA计划于2026年02月04日发布最新季度财报，市场关注盈利修复与收入持续扩大，围绕处方药分销与全球供应链韧性的讨论升温。市场一致预期显示，本季度CENCORA营收预计为860.27亿美元，同比增长9.75%；毛利率预测暂无披露；净利润或净利率预测暂无披露；调整后每股收益预计为4.02美元，同比增长14.65%；EBIT预计为10.62亿美元，同比增长15.52%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜CENCORA本季度营收预计增9.75%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COR"],"gpt_icon":0},{"id":"1177424094","title":"Cencora - 预计交易在关闭后首十二个月对公司的调整后摊薄每股收益影响为中性，融资成本净额考虑在内","url":"https://stock-news.laohu8.com/highlight/detail?id=1177424094","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177424094?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:02","pubTimestamp":1765800145,"startTime":"0","endTime":"0","summary":"Cencora - 预计交易在关闭后首十二个月对公司的调整后摊薄每股收益影响为中性，融资成本净额考虑在内","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","BK4529","LU1119994496.HKD","LU2324357040.USD","LU2237957902.USD","LU0289739699.SGD","COR","LU1430594728.SGD","BK4585","BK4588","LU2237957811.SGD","LU0058720904.USD","LU1084165304.USD","BK4175","BK4084","SG9999004303.SGD","SGXZ23171101.USD","LU1814569148.SGD","LU1261432733.SGD"],"gpt_icon":0},{"id":"1173801560","title":"Cencora - 公司全年度调整后摊薄每股收益更可能位于其指引范围的下半部分，即17.45美元至17.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173801560","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173801560?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:02","pubTimestamp":1765800141,"startTime":"0","endTime":"0","summary":"Cencora - 公司全年度调整后摊薄每股收益更可能位于其指引范围的下半部分，即17.45美元至17.75美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ23171101.USD","BK4588","LU1430594728.SGD","LU2324357040.USD","BK4529","LU2237957902.USD","BK4175","LU1119994496.HKD","LU2237957811.SGD","COR","BK4084","LU1585245621.USD","BK4585","SG9999004303.SGD","LU1261432733.SGD","LU1084165304.USD","LU1814569148.SGD","LU0289739699.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"1159333860","title":"在股息不受追捧的美股市场中值得买入的15只派息股","url":"https://stock-news.laohu8.com/highlight/detail?id=1159333860","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159333860?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:27","pubTimestamp":1763627234,"startTime":"0","endTime":"0","summary":"在过去的 100 年里，股息一直是股票市场总回报的重要组成部分。此外，标普 500 的股息预计在 2025 年将增长 5%。因此，要符合 Parker 的标准，有派息倾向的公司需要将股息支付占净利润比例控制在 40% 以下，同时拥有与市场相当的预期盈利增长。这些股票在过去 12 个月内均已提高或启动股息，平均股息支付占净利润不到 30%。不过，缺点是其平均收益率为 1.5%，虽高于标普 500，但低于该指数派息公司 2.4% 的平均收益率。","market":"us","thumbnail":"https://community-static.tradeup.com/news/1a6dc814ab395c7ae190b07ab231913b","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/1a6dc814ab395c7ae190b07ab231913b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f78c65c56b9e407a1521158bb4006352","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FG","CNK","AU","COR","NNI"],"gpt_icon":1},{"id":"1182593491","title":"Cencora第四季度调整后的每股收益为3.84美元，符合IBES预期的3.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182593491","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182593491?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:42","pubTimestamp":1763570526,"startTime":"0","endTime":"0","summary":"11月5日 - Cencora第四季度营收为837.29百万美元，超过IBES预期的834.13百万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU2324357040.USD","LU1814569148.SGD","LU0058720904.USD","LU2237957902.USD","LU1430594728.SGD","BK4084","LU1261432733.SGD","BK4529","LU1585245621.USD","BK4588","SG9999004303.SGD","LU1084165304.USD","BK4175","BK4585","SGXZ23171101.USD","LU2237957811.SGD","COR","LU1119994496.HKD"],"gpt_icon":0},{"id":"1176918340","title":"Cencora宣布计划到2030年投资10亿美元以增强和扩展其在美国的药品分销网络","url":"https://stock-news.laohu8.com/highlight/detail?id=1176918340","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176918340?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:03","pubTimestamp":1762344189,"startTime":"0","endTime":"0","summary":"Cencora宣布计划到2030年投资10亿美元，以增强和扩展其在美国的药品分销网络。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4084","LU2324357040.USD","LU1119994496.HKD","LU1084165304.USD","LU1814569148.SGD","LU0058720904.USD","LU1430594728.SGD","COR","BK4588","SGXZ23171101.USD","LU2237957811.SGD","BK4585","LU0289739699.SGD","LU2237957902.USD","LU1585245621.USD","LU1261432733.SGD","BK4175","BK4529","SG9999004303.SGD"],"gpt_icon":0},{"id":"1135885948","title":"Cencora宣布至2030年投资10亿美元 加强美国分销网络、扩大产能与增强韧性","url":"https://stock-news.laohu8.com/highlight/detail?id=1135885948","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135885948?lang=zh_cn&edition=full","pubTime":"2025-11-05 19:51","pubTimestamp":1762343475,"startTime":"0","endTime":"0","summary":"Cencora宣布至2030年将投资10亿美元，以加强其在美国的分销网络、扩大产能并提高韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1430594728.SGD","LU0058720904.USD","BK4175","SG9999004303.SGD","LU1084165304.USD","BK4529","BK4585","COR","LU2237957902.USD","LU0289739699.SGD","LU1261432733.SGD","LU1814569148.SGD","LU1119994496.HKD","BK4084","LU2237957811.SGD","LU1585245621.USD","SGXZ23171101.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"1188192292","title":"Cencora - 自2026年第一季度起，公司报告结构将包括美国医疗解决方案、国际医疗解决方案及其他","url":"https://stock-news.laohu8.com/highlight/detail?id=1188192292","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188192292?lang=zh_cn&edition=full","pubTime":"2025-11-05 19:37","pubTimestamp":1762342632,"startTime":"0","endTime":"0","summary":"Cencora - 自2026年第一季度起，公司报告结构将包括美国医疗解决方案、国际医疗解决方案及其他。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1261432733.SGD","LU1430594728.SGD","BK4529","LU0289739699.SGD","SGXZ23171101.USD","BK4588","BK4585","BK4175","COR","LU2237957902.USD","LU1119994496.HKD","SG9999004303.SGD","LU1585245621.USD","LU0058720904.USD","LU1814569148.SGD","BK4084","LU1084165304.USD","LU2237957811.SGD","LU2324357040.USD"],"gpt_icon":0},{"id":"2579498627","title":"【方正金融】中国人保9M25业绩点评：COR边际大幅改善，人身险业务维持高增","url":"https://stock-news.laohu8.com/highlight/detail?id=2579498627","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579498627?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:14","pubTimestamp":1761916440,"startTime":"0","endTime":"0","summary":"正文部分事件：中国人保披露9M25业绩，符合预期。净利润增长提速预计因巨灾减弱承保利润增厚以及投资收益提升。财险业务COR边际大幅改善。寿险业务价值维持高增速。健康险业务高质量增长趋势延续。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-10-31/doc-infvuxsp5494670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1585245621.USD","BK4529","LU1934453819.USD","LU1119994496.HKD","LU2324357040.USD","LU2237957902.USD","LU0289739699.SGD","LU1979443071.USD","COR","LU1430594728.SGD","BK4585","BK4588","LU2237957811.SGD","159940","LU0058720904.USD","LU1084165304.USD","BK4175","BK4084","SG9999004303.SGD","BK0207","SGXZ23171101.USD","LU1814569148.SGD","601319","LU1261432733.SGD"],"gpt_icon":0},{"id":"2513790918","title":"【研报掘金｜华泰证券：上调中国再保险目标价至1.1港元 去年盈利超预期】华泰证券发表研究报告指，中国再保险预计2024年归母净利润按年升80%至100%，超出该行预期。该行认为，公司利润高速增长，或主要受投资业绩高增以及保险业务稳健增长的驱动。该行预计，集团2024年人身再保险业务净利润有望增长236%，2024年全年财险业务COR达99.8%。该行表示，考虑到投资波动，将上年、今年及明年每股盈测上调至分别0.25元、0.21元及0.21元，目标价则由1港元上调至1.1港元，维持其评级为“买入”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513790918","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513790918?lang=zh_cn&edition=full","pubTime":"2025-02-24 13:49","pubTimestamp":1740376141,"startTime":"0","endTime":"0","summary":"华泰证券发表研究报告指，中国再保险预计2024年归母净利润按年升80%至100%，超出该行预期。该行认为，公司利润高速增长，或主要受投资业绩高增以及保险业务稳健增长的驱动。该行预计，集团2024年人身再保险业务净利润有望增长236%，2024年全年财险业务COR达99.8%。该行表示，考虑到投资波动，将上年、今年及明年每股盈测上调至分别0.25元、0.21元及0.21元，目标价则由1港元上调至1.1港元，维持其评级为“买入”。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24134948338990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["COR","01508","06886"],"gpt_icon":0},{"id":"2509764246","title":"【沃尔格林联合博姿继续出售Cencora股份 套现约3亿美元】 美国连锁药店沃尔格林联合博姿周四表示，已出售更多药品分销商Cencora的股份，套现约3亿美元。该公司目前在Cencora的持股比例从10%降至6%。此次出售股份所得将主要用于偿还债务和一般公司用途。（智通财经）","url":"https://stock-news.laohu8.com/highlight/detail?id=2509764246","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509764246?lang=zh_cn&edition=full","pubTime":"2025-02-07 14:41","pubTimestamp":1738910486,"startTime":"0","endTime":"0","summary":"美国连锁药店沃尔格林联合博姿周四表示，已出售更多药品分销商Cencora的股份，套现约3亿美元。该公司目前在Cencora的持股比例从10%降至6%。此次出售股份所得将主要用于偿还债务和一般公司用途。（智通财经）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/07144148009324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2237957811.SGD","BK4585","LU2237957902.USD","BK4084","LU1261432733.SGD","LU1119994496.HKD","LU1430594728.SGD","WBA","LU2324357040.USD","BK4529","LU0289739699.SGD","LU1084165304.USD","BK4588","COR","LU1585245621.USD","SG9999004303.SGD","SGXZ23171101.USD","LU0321505868.SGD","LU0321505439.SGD","BK4175","BK4128","LU0058720904.USD"],"gpt_icon":0},{"id":"1126125390","title":"Cencora 第一季度财报：肥胖药物和特殊药品推动收入和每股收益超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1126125390","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126125390?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:11","pubTimestamp":1738771872,"startTime":"0","endTime":"0","summary":"周三，Cencora, Inc公布其2025财年第一季度销售额增长12.8%，达到815亿美元，超过市场预期的783.8亿美元。公司报告的调整后每股收益为3.73美元，同比增长13.7%，超过市场预期的3.50美元。调整后的毛利润在2025年第一季度为25亿美元，比上一财年同期增长6.1%，这是由于两个报告部门的毛利润增加。Cencora预期调整后的摊薄每股收益为15.25至15.55美元，高于1月2日提供的15.15至15.45美元的范围以及最初的14.80至15.10美元的范围，市场预期为15.28美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCO","COR"],"gpt_icon":0},{"id":"2509404970","title":"Cencora(COR.US)：2025年Q1财报实现营收814.87亿美元，前值为722.53亿美元，预期值为782.2亿美元；每股收益为3.73美元，前值为3.28美元，预期值为3.52美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509404970","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509404970?lang=zh_cn&edition=full","pubTime":"2025-02-05 19:46","pubTimestamp":1738755995,"startTime":"0","endTime":"0","summary":"Cencora(COR.US)：2025年Q1财报实现营收814.87亿美元，前值为722.53亿美元，预期值为782.2亿美元；每股收益为3.73美元，前值为3.28美元，预期值为3.52美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05194647966049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["COR"],"gpt_icon":0},{"id":"1158459761","title":"Cencora 2025年第一季度调整后每股收益$3.73，超过预期的$3.50，销售额为$814.9亿，超过预期的$783.8亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1158459761","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158459761?lang=zh_cn&edition=full","pubTime":"2025-02-05 19:32","pubTimestamp":1738755166,"startTime":"0","endTime":"0","summary":"Cencora 报告其季度每股收益为$3.73，超过分析师普遍预期的$3.50，超出6.57%。与去年同期每股收益$3.28相比增长了13.72%。以上内容来自Benzinga Earnings专栏，原文如下：Cencora reported quarterly earnings of $3.73 per share which beat the analyst consensus estimate of $3.50 by 6.57 percent. This is a 13.72 percent increase over earnings of $3.28 per share from the same period last year. The company reported quarterly sales of $81.49 billion which beat the analyst consensus estimate of $78.38 billion by 3.96 percent. This is a 12.78 percent increase over ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cencora 2025年第一季度调整后每股收益$3.73，超过预期的$3.50，销售额为$814.9亿，超过预期的$783.8亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COR"],"gpt_icon":0},{"id":"2507682115","title":"富国银行：维持Cencora(COR.US)评级，由持股观望调整至持股观望评级, 目标价由237.00美元调整至251.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507682115","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507682115?lang=zh_cn&edition=full","pubTime":"2025-01-29 19:53","pubTimestamp":1738151599,"startTime":"0","endTime":"0","summary":"富国银行：维持Cencora(COR.US)评级，由持股观望调整至持股观望评级, 目标价由237.00美元调整至251.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29195347897048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["COR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cencora.com;investor.cencora.com","stockEarnings":[{"period":"1week","weight":-0.0731},{"period":"1month","weight":-0.1121},{"period":"3month","weight":-0.0587},{"period":"6month","weight":0.0397},{"period":"1year","weight":0.1989},{"period":"ytd","weight":-0.0507}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cencora, Inc.是全球最大的药品采购和分销服务公司之一，帮助医疗保健供应商以及制药和生物技术制造商改善患者获得产品加强患者护理的机会。该公司提供创新计划和服务，旨在提高药品供应链在人类和动物健康方面的效力和效率。更具体地说，该公司向位于美国和部分全球市场的各种医疗保健提供商提供全面的品牌、专业品牌和非专利药品、非处方医疗产品、家庭医疗用品和设备以及相关服务，包括急性病医院和卫生系统、独立和连锁零售药店、邮购药房、诊所、长期护理和替代地点药房、医师执业、医疗和透析诊所、兽医和其他客户。此外，公司还为医疗保健提供商和制药制造商提供各种相关服务，包括数据分析、结果研究、报销和药物咨询服务、利基优质物流服务、库存管理、药房自动化、药房管理和包装解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.050015},{"month":2,"riseRate":0.566667,"avgChangeRate":-0.001172},{"month":3,"riseRate":0.566667,"avgChangeRate":0.004226},{"month":4,"riseRate":0.586207,"avgChangeRate":0.016375},{"month":5,"riseRate":0.62069,"avgChangeRate":0.024176},{"month":6,"riseRate":0.533333,"avgChangeRate":0.029105},{"month":7,"riseRate":0.566667,"avgChangeRate":0.01258},{"month":8,"riseRate":0.6,"avgChangeRate":-0.009675},{"month":9,"riseRate":0.533333,"avgChangeRate":0.024726},{"month":10,"riseRate":0.566667,"avgChangeRate":-0.006226},{"month":11,"riseRate":0.7,"avgChangeRate":0.032788},{"month":12,"riseRate":0.533333,"avgChangeRate":0.013707}],"exchange":"NYSE","name":"CENCORA","nameEN":"Cencora Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CENCORA(COR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CENCORA(COR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CENCORA,COR,CENCORA股票,CENCORA股票老虎,CENCORA股票老虎国际,CENCORA行情,CENCORA股票行情,CENCORA股价,CENCORA股市,CENCORA股票价格,CENCORA股票交易,CENCORA股票购买,CENCORA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CENCORA(COR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CENCORA(COR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}